Is early chronic kidney disease an important risk factor for cardiovascular disease? A background paper prepared for the UK consensus conference on early chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 22, Issue SUPPL.9, 2007, Pages

  Daly, Conal ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; REVIEW; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RISK FACTORS; SEX FACTORS;

EID: 41149167274     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm445     Document Type: Conference Paper

References (62)

1. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 [12 suppl]: S16-S23
2. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615
3. National Kidney FoundationK/DOQUI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 [Suppl 2]: S1-S246
4. U.S. Renal Data System, USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005
5. Scottish Renal Association (2003). Scottish Renal Registry Report, 2001. Information & Statistics Division, Edinburgh
6. Owen W, Jr, Roberts J, Alexander S et al. NKF-DOQI clinical practice guidelines for hemodialysis adequacy. Am J Kid Dis 1997; 30 [3 Supp 2]: S15-S64
7. Golper T, Churchill D, Burkart J et al. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kid Dis 1997; 30 [3 Supp 2]: S67-S134
8. Schwab S, Besarab A, Beathard G et al. NKF-DOQI clinical practice guidelines for vascular access. Am J Kid Dis 1997; 30 [4 Supp 3]: S150-S191
9. Eschbach JW, DeOreo PB, Adamson JW et al. NKF-DOQI clinical practice guidelines for the treatment of anemia in chronic renal failure. Am J Kid Dis 1997; 30 [4 Supp 3]: S192-S240
10. Levey AS, Beto JA, Coronado BE et al. Controlling the epidemic of cardiovascular disease in chronic renal disease. What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 1998; 32: 853-906
11. Eknoyan G. On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: A first step to improve the outcomes. Am J Kidney Dis 1998; 32 [5 Suppl 3]: S1-S4
12. U.S. Renal Data System: USRDS 1998 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 1998
13. Foley RN, Murray AM, Shuling L et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495
14. Keith DS, Nichols GA, Gullion CM et al. Longitudinal followup and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663
15. Joint Speciality Committee on Renal Medicine of the Royal College of Physicians and the Renal Association, and the Royal College of General Practitioners. Chronic kidney disease in adults: UK guidelines for identification, management and referral. Royal College of Physicians, London: 2006
16. The CARI guidelines- Caring for Australians with renal impairment. Chronic kidney disease - Evaluation of renal function 2005. http://www.cari.org. au (Accessed August 2006
17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
18. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
19. Klahr S, Levey AS, Beck GJ et al. The effects of dietary protein restriction and blood-pressure control on the progression of renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994; 330: 877-884
20. Narins RG, Cortes P. The role of dietary protein restriction in progressive azotemia.[Editorial]. N Engl J Med 1994; 330: 929-930
21. Levey AS, Adler S, Caggiula AW et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1996; 27: 652-663
22. Levey AS, Coresh J, Greene T et al. for the Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254
23. Beck GJ, Berg RL, Coggins CH et al. Design and statistical issues of the modification of diet in renal disease trial. The Modification of Diet in Renal Disease Study Group. Control Clin Trials 1991; 12: 566-586
24. Kusek JW, Coyne T, de Velasco A et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Control Clin Trials 1993; 14: 538-557
25. U.S. Renal Data System: USRDS 1994 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, June 1994
26. Foley RN, Parfrey PS, Harnett JD. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192
27. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 2000; 35 [Suppl 1]: S117-S131
28. Zocalli C. Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? Nephrol Dial Transplant 2000; 15: 454-457
29. Coronado B, Beck G, Greene T et al. Cardiovascular disease risk factors and GFR in the MDRD study. J Am Soc Nephrol 1997; 135A
30. Ruilope LM, Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 12: 218-225
31. Schillaci G, Reboldi G, Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med 2001; 161: 886-891
32. Pahor M, Shorr RI, Somes GW. Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. Arch Intern Med 1998; 158: 1340-1345
33. Mann JF, Gerstein HC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636
34. Jungers P, Massy ZA, Nguyen Khoa T et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 1997; 12: 2597-2602
35. Sechi LA, Zingaro L, De Carli S et al. E: Increased serum lipoprotein(a) levels in patients with early renal failure. Ann Intern Med 1998; 129: 457-461
36. Sechi LA, Zingaro L, Catena C et al. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure. Kidney Int 1999; 56: 1049-1057
37. Culleton BF, Larson MG, Wilson PW et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-2219
38. Shulman NB, Ford CE, Hall WD et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13 [Suppl 1]: 80-93
39. Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased stroke. Stroke 1997; 28: 557-563
40. Fried LP, Kronmal RA, Newman AB et al. Risk factors for fiveyear mortality in older adults. The Cardiovascular Health Study. JAMA 1998; 279: 585-592
41. Matts JP, Karnegis JN, Campos CT et al. Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. J Fam Pract 1993; 36: 497-503
42. Hemmelgarn BR, Ghali WA, Quan H et al. Poor long-Term survival after coronary angiography in patients with renal insufficiency. Am J Kidney Dis 2001; 37: 64-72
43. Damsgaard EM, Froland A, Jorgensen OD et al. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297-300
44. Beattie JN, Soman SS, Sandberg KR et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001; 37: 1191-1200
45. Friedman PJ. Serum creatinine: An independent predictor of survival after stroke. J Intern Med 1991; 229: 175-179
46. Wagner DK, Harris T, Madans JH. Proteinuria as a biomarker: risk of subsequent morbidity and mortality. Environ Res 1994; 66: 160-172
47. Ljungman S, Wikstrand J, Hartford M et al. Urinary albumin excretion-A predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-Aged nondiabetic normal and hypertensive men. Am J Hypertens 1996; 9: 770-778
48. Culleton BF, Larson MG, Parfrey PS et al. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study. Am J Med 2000; 109: 1-8
49. Miettinen H, Haffner SM, Lehto S et al. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 1996; 27: 2033-2039
50. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol 1997; 80: 164-169
51. Jager A, Kostense PJ, Ruhe HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624
52. Grimm RH,Jr, Svendsen KH, Kasiske B et al. Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple risk factor intervention trial. Kidney Int 1997; 63: S10-S14
53. Kannel WB, Stampfer MJ, Castelli WP et al. The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984; 108: 1347-1352
54. Garg AX, Clark WF, Haynes RB et al. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 2002; 61: 1486-1494
55. Dries DL, Exner DV, Domanski MJ et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000; 35: 681-689
56. Manolio TA, Kronmal RA, Burke GL et al. Short-Term predictors of incident stroke in older adults. The Cardiovascular Health Study. Stroke 1996; 27: 1479-1486
57. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315
58. The Atherosclerosis Risk in Communities (ARIC) StudyDesign and objectives. The ARIC investigators. Am J Epidemiol 1989; 129: 687-702
59. Fried LP, Borhani NO, Enright P et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991; 1: 263-276
60. Dawber TR, Kannel WB. An epidemiologic study of heart disease: the Framingham Study. Nutr Rev 1958; 16: 1-4
61. Kannel WB, Feinleib M, McNamara PM et al. An investigation of coronary heart disease in families. The Framingham Offspring Study. Am J Epidemiol 1979; 110: 281-290
62. Weiner DE, Tabatabai S, Tighiouart H et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 2006; 48: 392-401